JICXMOHTRJFUGV-FQEVSTJZSA-N
C32H37F2N9O4S — CID 135186623
Data last refreshed: (MolForge compound catalog, from PubChem)
About JICXMOHTRJFUGV-FQEVSTJZSA-N
JICXMOHTRJFUGV-FQEVSTJZSA-N (PubChem CID 135186623) has the molecular formula C32H37F2N9O4S and a molecular weight of 681.77 g/mol. Its IUPAC name is N-[3-[(2S)-6-(difluoromethoxy)-2-methyl-3,4-dihydro-2H-1,4-benzothiazin-7-yl]-1-[2-[4-(morpholin-4-ylmethyl)piperidin-1-yl]-2-oxoethyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | JICXMOHTRJFUGV-FQEVSTJZSA-N |
|---|---|
| PubChem CID | 135186623 |
| Molecular Formula | C32H37F2N9O4S |
| Molecular Weight | 681.77 g/mol |
| Exact Mass | 681.27 |
| IUPAC Name | N-[3-[(2S)-6-(difluoromethoxy)-2-methyl-3,4-dihydro-2H-1,4-benzothiazin-7-yl]-1-[2-[4-(morpholin-4-ylmethyl)piperidin-1-yl]-2-oxoethyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | C[C@H]1CNc2cc(OC(F)F)c(-c3nn(CC(=O)N4CCC(CN5CCOCC5)CC4)cc3NC(=O)c3cnn4cccnc34)cc2S1 |
| InChI | InChI=1S/C32H37F2N9O4S/c1-20-15-36-24-14-26(47-32(33)34)22(13-27(24)48-20)29-25(38-31(45)23-16-37-43-6-2-5-35-30(23)43)18-42(39-29)19-28(44)41-7-3-21(4-8-41)17-40-9-11-46-12-10-40/h2,5-6,13-14,16,18,20-21,32,36H,3-4,7-12,15,17,19H2,1H3,(H,38,45)/t20-/m0/s1 |
| InChIKey | JICXMOHTRJFUGV-FQEVSTJZSA-N |
| XLogP | 3.92 |
| TPSA | 131.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 681.77 |
| LogP ≤ 5 | 3.92 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135186623 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.